MedTrace Logo

Efficacy/Safety of Lansoprazole in Patients With Frequent Nighttime Heartburn

NCT00701259 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 852

Last updated 2010-01-15

No results posted yet for this study

Summary

Heartburn, a burning sensation in the chest or throat, occurs in many individuals when acidic stomach contents move upward into the esophagus from the stomach. This study will investigate the safety and efficacy of lansoprazole 15 mg or 30 mg administered once a day in preventing frequent nighttime heartburn.

Conditions

  • Frequent Heartburn

Interventions

DRUG

Lansoprazole

Lansoprazole 15 mg once per day for 14 days

DRUG

Lansoprazole

Lansoprazole 30 mg once per day for 14 days

DRUG

placebo

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Completion
2007-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00701259 on ClinicalTrials.gov